Facts versus theories: An everlasting struggle

Cerebrovascular Diseases

Volumn 30, Issue 4, 2010, Pages 330-339

  Van Gijn, Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Aspirin; History of neurology; Johann Jakob Wepfer; Scientific methods; Subarachnoid haemorrhage

Indexed keywords

ACETYLSALICYLIC ACID;

BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; HISTORY OF MEDICINE; HUMAN; LEG ISCHEMIA; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; STROKE; SUBARACHNOID HEMORRHAGE;

ASPIRIN; AWARDS AND PRIZES; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPE; HISTORY, 17TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; NEUROLOGY; PLATELET AGGREGATION INHIBITORS; SOCIETIES, MEDICAL; STROKE;

EID: 77955201544     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319571     Document Type: Review

References (59)

1. Van der Worp HB, van Gijn J: Acute ischemic stroke (clinical practice). N Engl J Med 2007;357:572-579.
2. van Gijn J, Kerr RS, Rinkel G J E: Subarachnoid haemorrhage. Lancet 2007;369:306-318.
3. Pratensis J: De cerebri morbis. Basle, Henricus Petri, 1549.
4. Wepfer JJ: Observationes anatomicae, ex cadaveribus eorum, quos sustulit apoplexia, cum exercitatione de eius loco affecto. Schaffhausen, Suteri, 1658.
5. Wepfer JJ: Observationes anatomicae, ex cadaverum eorum, quos sustulit apoplexia. Cum exercitatione de eius loco affecto. Novae ed. Schaffhausen, Onophrius, 1675.
6. Karenberg A: Johann Jakob Wepfers Buch über die Apoplexie (1658). Kritische Anmerkungen zu einem Klassiker der Neurologie. Nervenarzt 1998;69:93-98.
7. Karenberg A: Johann Jakob Wepfer (1620-1695). J Neurol 2004;251:501-502.
8. Harvey W: Exercitatio anatomica de motu cordis et sanguinis in animalibus. Frankfurt, Fitzer, 1628.
9. Portal A: Observations sur la nature et le traitement de l'apoplexie, et sur les moyens de la prévenir. Paris, Crochard, 1811.
10. Morgagni GB: De sedibus et causis morborum per anatomen indigatis libri quinque. Venice, ex typographica Remondiana, 1761.
11. Ackerknecht EH: Medicine at the Paris Hospital 1794-1848. Baltimore, The Johns Hopkins Press, 1967.
12. Hannaway C, La Berge A (eds): Constructing Paris Medicine. Amsterdam, Rodopi, 1998.
13. Rostan L: Recherches sur le ramollissement du cerveau. Ouvrage dans lequel on s'efforce de distinguer les diverses affections de ce viscère par des signes caractéristiques. Paris, Béchet, 1820.
14. Warlow C, van Gijn J, Dennis M, Wardlaw J, Bamford J, Hankey G, et al: Stroke - Practical Management, 3rd ed. Oxford, Blackwell, 2008.
15. Russell Reynolds J, Bastian HC: Congestion of the brain; in Russell Reynolds J (ed): A System of Medicine. Philadelphia, Lippincott, 1866, vol 2, pp 413-429.
16. Hammond WA: Cerebral Hyperaemia. New York, Putnam, 1878.
17. Buckley CF: Cerebral Hyperaemia - Does It Exist? New York, Putnam, 1882.
18. Gowers WR: A Manual of Diseases of the Nervous System. London, Churchill, 1888.
19. Hill L: The experimental pathology of the cerebral circulation; in Albutt C, Rolleston HD (eds): A System of Medicine. London, Macmillan, 1910, vol 8, pp 4-37.
20. Kinnier Wilson SA: Cerebral hyperaemia; in Kinnier Wilson SA, Bruce NA (eds): Neurology. London, Arnold, 1941, vol 2, pp 1061-1063.
21. Eastcott H H G, Pickering GW, Rob CG: Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet 1954;264:994-996.
22. Warlow C: Carotid endarterectomy: does it work? Stroke 1984;15:1068-1076.
23. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, et al: Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361:107-116.
24. van Gijn J: What dose of aspirin is most likely to reduce the risk of stroke?; in Warlow C, Garfield J (eds): More Dilemmas in the Management of the Neurological Patient. Edinburgh, Churchill Livingstone, 1987, vol 1, pp 145-155.
25. Dyken ML, Barnett H J M, Easton JD, Fields WS, Fuster V, Hachinski V, et al: Low-dose aspirin and stroke. 'It ain't necessarily so'. Stroke 1992;23:1395-1399.
26. Baigent C, Sudlow C, Collins R, Peto R, for the Antithrombotic Trialists Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
27. Kallmann R, Nieuwenhuis HK, de Groot PG, van Gijn J, Sixma JJ: Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects. Thromb Res 1987;45:355-361.
28. Dippel DW, van Kooten F, Leebeek FW, van Vliet HH, Mehicevic A, Li SS, et al: What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke? Cerebrovasc Dis 2004;17:296-302.
29. The Dutch TIA Trial Study Group: A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991;325:1261-1266.
30. Jüni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M: Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004;364:2021-2029.
31. Wadman M: How does a painkiller harm the heart? Nature 2006;441:262.
32. Vermeulen M, Lindsay KW, Murray GD, Cheah F, Hijdra A, Muizelaar JP, et al: Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 1984;311:432-437.
33. Wulff HR: Rational Diagnosis and Treatment - An Introduction to Clinical Decision-Making. Oxford, Blackwell, 1981.
34. Schwartz D, Flamant R, Lellouch J: Clinical Trials. London, Academic Press, 1980.
35. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989;298:636-642.
36. Hill AB: Principles of Medical Statistics. London, The Lancet, 1967.
37. Millikan CH: Cerebral vasospasm and ruptured intracranial aneurysm. Arch Neurol 1975;32:433-449.
38. Vergouwen M D I, Vermeulen M, van Gijn J, Rinkel G J E, Wijdicks E F M, Muizelaar JP, et al: Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies - Proposal of a multidisciplinary research group. Submitted.
39. Rabinstein AA, Friedman JA, Weigand SD, McClelland RL, Fulgham JR, Manno EM, et al: Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004;35:1862-1866.
40. Weidauer S, Lanfermann H, Raabe A, Zanella F, Seifert V, Beck J: Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study. Stroke 2007;38:1831-1836.
41. Lam J M K, Smielewski P, Czosnyka M, Pickard JD, Kirkpatrick PJ: Predicting delayed ischemic deficits after aneurysmal subarachnoid hemorrhage using a transient hyperemic response test of cerebral autoregulation. Neurosurgery 2000;47:819-825.
42. Minhas PS, Menon DK, Smielewski P, Czosnyka M, Kirkpatrick PJ, Clark JC, et al: Positron emission tomographic cerebral perfusion disturbances and transcranial Doppler findings among patients with neurological deterioration after subarachnoid hemorrhage. Neurosurgery 2003;52:1017-1022.
43. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al: Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008;39:3015-3021.
44. Hop JW, Rinkel G J E, Algra A, van Gijn J: Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 1999;30:2268-2271.
45. Öhman J, Servo A, Heiskanen O: Risks factors for cerebral infarction in good-grade patients after aneurysmal subarachnoid hemorrhage and surgery: a prospective study. J Neurosurg 1991;74:14-20.
46. Brouwers P J A M, Wijdicks E F M, van Gijn J: Infarction after aneurysm rupture does not depend on distribution or clearance rate of blood. Stroke 1992;23:374-379.
47. Wijdicks E F M, Vermeulen M, Hijdra A, van Gijn J: Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann Neurol 1985;17:137-140.
48. Wijdicks E F M, Vermeulen M, ten Haaf JA, Hijdra A, Bakker WH, van Gijn J: Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol 1985;18:211-216.
49. Eskesen V, Karle A, Kruse A, Kruse Larsen C, Praestholm J, Schmidt K: Observer variability in assessment of angiographic vasospasm after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 1987;87:54-57.
50. Hughes JT, Schianchi PM: Cerebral artery spasm - A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 1978;48:515-525.
51. Vergouwen M D I, Vermeulen M, Coert BA, Stroes ES, Roos Y B W E M: Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 2008;28:1761-1770.
52. van Gijn J, Hijdra A, Wijdicks E F M, Vermeulen M, van Crevel H: Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg 1985;63:355-362.
53. van Gijn J, van Dongen KJ, Vermeulen M, Hijdra A: Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology 1985;35:493-497.
54. Rinkel G J E, Wijdicks E F M, Hasan D, Kienstra GE, Franke CL, Hageman LM, et al: Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet 1991;338:964-968.
55. Rinkel G J E, Wijdicks E F M, Vermeulen M, Ramos L M P, Tanghe HL, Hasan D, et al: Nonaneurysmal perimesencephalic subarachnoid hemorrhage: CT and MR patterns that differ from aneurysmal rupture. AJNR Am J Neuroradiol 1991;12:829-834.
56. Ruigrok YM, Rinkel G J E, Buskens E, Velthuis BK, van Gijn J: Perimesencephalic hemorrhage and CT angiography - A decision analysis. Stroke 2000;31:2976-2983.
57. Wijdicks E F M, Schievink WI, Miller GM: Pretruncal nonaneurysmal subarachnoid hemorrhage. Mayo Clin Proc 1998;73:745-752.
58. Rinkel G J E, Wijdicks E F M, Vermeulen M, Tans J T J, Hasan D, van Gijn J: Acute hydrocephalus in nonaneurysmal perimesencephalic hemorrhage: evidence of CSF block at the tentorial hiatus. Neurology 1992;42:1805-1807.
59. Greebe P, Rinkel G J E: Life expectancy after perimesencephalic subarachnoid hemorrhage. Stroke 2007;38:1222-1224.